Elekta recently received FDA clearance for its Volumetric Modulated Arc Therapy (VMAT).
Reportedly empowering clinicians to treat more patients in significantly less time, Elekta VMAT offers the clinical efficacy of IMRT delivered in a fraction of the time, providing rapid treatment with daily 3D image guidance. Features of VMAT include faster treatment times, precise dose control, reduced radiation dose to healthy tissue and 3D Volumetric imaging.
Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...
October 21, 2025 
Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...
September 05, 2025 
May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...
May 03, 2025 
April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...
April 21, 2025 
April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...
April 17, 2025 
March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...
March 17, 2025 
Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...
November 13, 2024 
Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...
August 09, 2024 
July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...
July 31, 2024 
News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...
July 30, 2024 